FDA inspection
Abon Biopharm (Hangzhou) Co., Ltd.: FDA inspection ending Jul 10, 2012
FDA inspection 792168 · No Action Indicated (NAI) · Hangzhou
Key facts
| Inspection ID | 792168 |
|---|---|
| Firm | Abon Biopharm (Hangzhou) Co., Ltd. |
| FEI number | 3005641941 |
| Address | #198, #12 Street East, Hangzhou, Economic & Tech. Development Area |
| City | Hangzhou |
| Country | China |
| Fiscal year | 2012 |
| Inspection end date | Jul 10, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data